Brii Biosciences Limited (HKG:2137)
Hong Kong · Delayed Price · Currency is HKD 0.9600
-0.0700 (-6.80%)
Aug 27, 2026, 4:08 PM HKT
Brii Biosciences Market Cap
Brii Biosciences has a market cap or net worth of 743.46 million as of August 27, 2026. Its market cap has decreased by -47.82% in one year.
Market Cap
743.46M
Enterprise Value
-1.35B
Revenue
40.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.96
ChartMarket Cap Chart
Since July 13, 2021, Brii Biosciences's market cap has decreased from 16.21B to 743.46M, a decrease of -95.41%. That is a compound annual growth rate of -45.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 743.46M | -26.89% |
| Dec 31, 2025 | 1.02B | 41.89% |
| Dec 31, 2024 | 716.67M | -56.90% |
| Dec 29, 2023 | 1.66B | -68.96% |
| Dec 30, 2022 | 5.36B | -77.39% |
| Dec 31, 2021 | 23.70B | 46.22% |
| Jul 13, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CANbridge Pharmaceuticals | 1.18B |
| Cloudbreak Pharma | 1.01B |
| Sunho Biologics | 970.43M |
| Kintor Pharmaceutical | 834.54M |
| JW (Cayman) Therapeutics Co. | 817.88M |
| 3D Medicines | 750.06M |
| Cutia Therapeutics | 726.74M |
| Wuhan YZY Biopharma | 639.70M |